Thank you for sharing!

Your article was successfully shared with the contacts you provided.
Drug prices The group is attacking PBMs and “short-sighted policies that would disrupt the development of the cures and medicines that patients depend on.” (Photo: Shutterstock)

A “shadowy” drug pricing advocacy organization that made its first appearance this week has proved to be backed by a Republican lobbying firm.

Marlene Satter


Join BenefitsPRO

Don’t miss crucial news and insights you need to navigate the shifting employee benefits industry. Join BenefitsPRO.com now!

  • Unlimited access to BenefitsPRO.com - your roadmap to thriving in a disrupted environment
  • Access to other award-winning ALM websites including ThinkAdvisor.com and Law.com
  • Exclusive discounts on BenefitsPRO.com and ALM events.

Already have an account? Sign In Now
Join BenefitsPRO

Copyright © 2019 ALM Media Properties, LLC. All Rights Reserved.